Ceutics exam 4 voacb

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/58

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 5:31 PM on 8/16/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

59 Terms

1
New cards

The study of how the physicochemical properties of drugs, dosage forms, and route of administration affect the rate and extent of drug absorption

Biopharmaceutics

2
New cards

The rate and extent of therapeutically active drug reaching the systemic circulation

Bioavailability

3
New cards

IV reference (absolute or relative F)

Absolute

4
New cards

Compare formulation to a recognized standard

Relative F

5
New cards

The absence of a significant difference in the rate and extent to which the active moiety in pharmaceutical equivalents or alternatives becomes available at the site of drug action when administered at the same molar dose

Bioequivalence (B/E)

6
New cards

Passage through cells

Transcellular

7
New cards

Passage between cells

Paracellular

8
New cards

Drugs must pass through _____ barrier(s)

Multiple

9
New cards

A process of mass transfer of molecules across the plasma membrane from high concentration to low concentration

Simple diffusion

10
New cards

This law is used to describe the diffusion of a drug across the rate limiting barrier of the cell

Fick’s

11
New cards

Chemical and physical integrity of the dosage unit and when appropriate the ability of the dosage unit to maintain protection against microbiological contamination

Stability according to <1150>

12
New cards

Time from date of manufacture that a drug product will remain in its approved product specifications while stores under defined conditions

Shelf life

13
New cards

t(90)

Time after manufacture or preparation until the product contains 90% of its original strength

14
New cards

Final day that the manufacture guarantees the full potency and safety of a drug or shortest time at which the article may be expected to meet the requirements of the compendia, monograph under prescribed storage conditions

Expiration date

15
New cards

Increase in the number of C-O bonds in a molecule (loss of electrons) or a reduction in the number of C-H bonds

Oxidation

16
New cards

Absorb wavelengths of light to induce photolysis, primarily oxidation type reactions

Photodegradation

17
New cards

Breaking of molecular bonds by reaction with water

Hydrolysis

18
New cards

Most common cause of chemical degredation

Hydrolysis

19
New cards

The date after which an article shall no be used

Beyond use date

20
New cards

Amide in a ring

Lactams

21
New cards

Ester in a ring

Lactones

22
New cards

Due to free radicals and is often catalyzed by trace metals, light, heat

Oxidation

23
New cards

Oxidative reactions generally result in the ______ of ______ and/or removal of _____

Additional, oxygen, hydrogen

24
New cards

Conversion of a hydrogen to a hydroxyl group

Hydroxylation

25
New cards

Conversion of a hydroxyl group to a carbonyl group

Dehydrogenation

26
New cards

Conversion of carbonyl group to a carboxyl group

Carboxylation

27
New cards

Conversion of an amino group to a carbonyl group

Deamination

28
New cards

Conversion of a methyl group to a hydrogen

Demethylation

29
New cards

__ are readily oxidized to quinones

Catechols

30
New cards

___ oxidized via complex pathways and yield various products

Phenothiazines

31
New cards

These molecules are susceptible to oxidation

Polyunsaturated molecules

32
New cards

__oxidized to disulfides

Thiols

33
New cards

___ interrupt the propagation by interacting with the free radical

Antioxidants

34
New cards

More susceptible to oxidation and are preferably oxidized to consume the available oxygen

Suicide substrate

35
New cards

SLC15

proton of oligopeptide cotransporters

36
New cards

SLC21/SLCO

organic anion trasnporting polypeptides

37
New cards

SLC22

organic cation/anion/zwitterion transporters

38
New cards

SLC29

facilitative nucleoside transporter

39
New cards

ABCB1

P-gp, MDR1

40
New cards

ABCB11

bile salt export protein

41
New cards

ABCC1-C9

multi-drug resistance

42
New cards

ABCG2

breast cancer resistance protein

43
New cards

this ABC typically transports drug conjugates since too hydrophilic to move passively

ABCC1-C9

44
New cards

Define tablet

compressed solid dosage forms that consist of one or more active ingredients together with various excipients

45
New cards

True or false: sublingual tablets have a faster onset than buccal

true

46
New cards

what are the two types of FDC

layered and tablet in tablet

47
New cards

define layered tablet

compression of an additional granulation on a previous compressed granulation

48
New cards

define tablet in tablet

compress second granulation on first performed tablet

49
New cards

what releases in effervescent tablets

carbon dioxide

50
New cards

what does the carbon dioxide to for the effervescent tablets 

assist with flavor, disintegration and dissolution

51
New cards

true or false: lubricants in tablets have nothing to do with physiological properties

true

52
New cards

define wicking

water is pulled into pores by disintegrant and reduce the physical bonding forces between particles

53
New cards

define swelling

particles swell and breakup the matrix from within; blows the tablet apart

54
New cards

what do hard gelatin capsules also contain other than gelatin and water

colorants and opacifying agents

55
New cards

the smaller the capsule size, the _____ the drug capacity

bigger

56
New cards

enteric coatings wait to release drug in a less ____ environment

acidic

57
New cards

true or false: because there is a coating, means the tablet can not be crushed or split

false

58
New cards

define reservoir

dosage form where the drug is enclosed within a rate controlling memBrane

59
New cards

define matrix

drug is embedded in an insoluble excipient to achieve sustained release